Recombinant adenoviruses expressing TRAIL demonstrate antitumor effects on non-small cell lung cancer (NSCLC)

By Yang F.   Shi P.   Xi X.   Yi S.   Li H.   Sun Q.   Sun M.  

Medical Oncology, Vol. 23, Iss. 2, 2006-06 ,pp. : 191-204

Humana Press, Inc

Access to resources Recommend Favorite

Phase II trial with ISIS 5132 in patients with small-cell (SCLC) and non-small cell (NSCLC) lung cancer. A European Organization for Research and Treatment of Cancer (EORTC) Early Clinical Studies Group report

By Coudert B.   Anthoney A.   Fiedler W.   Droz J.P.   Dieras V.   Borner M.   Smyth J.F.   Morant R.   de Vries M.J.   Roelvink M.   Fumoleau P.  

European Journal of Cancer, Vol. 37, Iss. 17, 2001-01 ,pp. : 2194-2198

Elsevier

Access to resources Recommend Favorite

Radiation-induced apoptosis in human non-small-cell lung cancer cell lines is secondary to cell-cycle progression beyond the G2-phase checkpoint

By Stuschke M.   Sak A.   Wurm R.   Sinn B.   Wolf G.   Stüben G.   Budach V.  

International Journal of Radiation Biology, Vol. 78, Iss. 9, 2002-09 ,pp. : 807-819

Informa Healthcare

Access to resources Recommend Favorite

Establishment and characterization of human non-small cell lung cancer cell lines

By                          

Molecular Medicine Reports, Vol. 5, Iss. 1, 2012-01 ,pp. : 114-117

Spandidos Publications

Access to resources Recommend Favorite

Combined Modality Treatment in Small Cell Lung Cancer (SCLC)

By Gregor A.  

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 816-818

Elsevier

Access to resources Recommend Favorite